Amedisys Inc
NASDAQ:AMED
Amedisys Inc
NASDAQ:AMED
Price:
91.84 USD
0.05%
Market Closed
Updated:
Apr 30, 2024
Amedisys Inc
Revenue
|
Amedisys Inc
Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Revenue
$2.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Amedisys Inc
Revenue Breakdown
Breakdown by Geography
Amedisys Inc
Amedisys Inc
Not Available
Breakdown by Segments
Amedisys Inc
Amedisys Inc
|
Total Revenue:
2.2B
USD
|
|
Home Health:
1.4B
USD
|
|
Hospice:
798.8m
USD
|
|
High Acuity Care:
19m
USD
|
|
Personal Care:
15m
USD
|
See Also
What is Amedisys Inc's Revenue?
Revenue
2.2B
USD
2.2B
USD
Based on the financial report for Dec 31, 2023, Amedisys Inc's Revenue amounts to 2.2B USD.
What is Amedisys Inc's Revenue growth rate?
Revenue CAGR 10Y
6%
6%
Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for Amedisys Inc have been 3% over the past three years , 6% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
